Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 1, subfamily B, polypeptide 1 | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 2 | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 1 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Cytochrome P450 family protein | cytochrome P450, family 1, subfamily A, polypeptide 1 | 512 aa | 505 aa | 26.7 % |
Brugia malayi | Cytochrome P450 family protein | cytochrome P450, family 1, subfamily A, polypeptide 2 | 516 aa | 470 aa | 26.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | acyl-CoA desaturase | 0.071 | 0.5 | 0.5 |
Plasmodium falciparum | stearoyl-CoA desaturase | 0.071 | 0.5 | 0.5 |
Leishmania major | stearic acid desaturase, putative | 0.071 | 0.5 | 0.5 |
Trypanosoma brucei | fatty acid desaturase, putative | 0.071 | 0.5 | 0.5 |
Onchocerca volvulus | 0.071 | 0.5 | 0.5 | |
Onchocerca volvulus | 0.071 | 0.5 | 0.5 | |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.071 | 0.5 | 0.5 |
Leishmania major | fatty-acid desaturase, putative | 0.071 | 0.5 | 0.5 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.071 | 0.5 | 0.5 |
Plasmodium vivax | stearoyl-CoA desaturase (acyl-CoA desaturase, faty acid desaturase), putative | 0.071 | 0.5 | 0.5 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.071 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 0.8 uM | Activation of Nrf2 (unknown origin) expressed in human HepG2 cells after 5 hrs by ARE-driven luciferase reporter gene assay | LITERATURE. | 28126440 |
FC (binding) | = 12.9 | Activation of Nrf2 (unknown origin) expressed in human HepG2 cells after 5 hrs by ARE-driven luciferase reporter gene assay relative to control | LITERATURE. | 28126440 |
IC50 (ADMET) | = 3.51 nM | Inhibition of human CYP1A1 expressed in Escherichia coli assessed as changes in ethoxyresorufin O-deethylation activity after 3 mins by spectrofluorometer analysis | ChEMBL. | No reference |
IC50 (ADMET) | = 302 nM | Inhibition of human CYP1A2 expressed in Escherichia coli assessed as changes in ethoxyresorufin O-deethylation activity after 3 mins by spectrofluorometer analysis | ChEMBL. | No reference |
IC50 (binding) | = 350 nM | Inhibition of human CYP1B1 expressed in Escherichia coli assessed as changes in ethoxyresorufin O-deethylation activity after 3 mins by spectrofluorometer analysis | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.